A Taste Assessment of BMS-986165 in Healthy Participants

Completed · Phase 1

Conditions studied: Healthy Participants

In brief

The purpose of this study is to assess the taste characteristics of BMS-986165 formulations, alone and mixed, in order to develop a pediatric oral form of BMS-986165.

Key facts

Study ID

NCT03751228

Run by

Bristol-Myers Squibb

People needed

9

Starts

2018-10-11

Expected to finish

2018-11-26

Last updated by the study team

2019-10-01

Who can join

Age: 25 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• WOCBP must agree to follow instructions for method(s) of contraception for 5 half-lives of BMS-986165 (2 days) plus 30 days (duration of ovulatory cycle) for a total of 32 days after each tasting day.
• Males who are sexually active with WOCBP must agree to follow instructions for method(s) of contraception 5 half-lives of the study drug (2 days) after each tasting day.

You may not qualify if…

• A known sensitivity to BMS-986165
• A history of any illness that, in the opinion of the investigator, might confound the results of the study or pose an additional risk in administering study drug(s) to the participant. This may include but is not limited to: a history of relevant drug or food allergies; history of cardiovascular or central nervous system disease; history or presence of clinically significant pathology; or history of mental disease
• Other protocol defined inclusion/exclusion criteria could apply

Where it is running

• Senopsys — Woburn, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.